Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BIOCELTIX S.A. ZY -,10
No Price
Closing Price XWAR 29.04.2026:
88,00 PLN
29.04.2026 10:47
Current Prices from BIOCELTIX S.A. ZY -,10
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
WSE
BCX.WA
PLN
29.04.2026 10:47
88,00 PLN
-0,60 PLN
-0,68 %
Share Float & Liquidity
Free Float69,25 %
Shares Float3,83 M
Shares Outstanding5,53 M
Company Profile for BIOCELTIX S.A. ZY -,10 Share
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.
